MARGINAL ZONE LYMPHOMA RECURRENT

MARGINAL ZONE LYMPHOMA RECURRENT was reported 48 times

MARGINAL ZONE LYMPHOMA RECURRENT is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD20-directed Cytolytic Antibody [EPC] 40 0.0001
1 Alkylating Drug [EPC] 26 0.0001
2 Topoisomerase Inhibitor [EPC] 4 0.0001
3 Platinum-based Drug [EPC] 13 0.0000
4 Corticosteroid [EPC] 34 0.0000
5 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
6 Xanthine Oxidase Inhibitor [EPC] 3 0.0000
7 Nucleoside Metabolic Inhibitor [EPC] 4 0.0000
8 Azole Antifungal [EPC] 2 0.0000
9 Kinase Inhibitor [EPC] 6 0.0000
10 Janus Kinase Inhibitor [EPC] 1 0.0000
11 Thalidomide Analog [EPC] 3 0.0000
12 Factor Xa Inhibitor [EPC] 1 0.0000
13 Nonsteroidal Anti-inflammatory Drug [EPC] 2 0.0000